Vaccines Market - Forecast(2020 - 2025)

Report Code: HCR 0711 Report Format: PDF + Excel (Delivery in 48 Hrs)
Vaccines Market Overview 
Vaccines Market size is valued at $42.9Bn in 2019 and is anticipated to grow at a CAGR of 6.6% during the forecast period 2020-2025. The Vaccines Market growth rate is attributed to the advancements made in the healthcare sector such as medical technology and medicines, along with the rising focus on immunization. From improvement’s made in the company initiatives to enhance vaccine R&D to the various nation wise initiatives taken by the governmental bodies for the betterment of the people is anticipated propel the vaccines market during the forecast period 2020-2025.   

Key Takeaways
  • North America dominated the Vaccines Market with a share of 48% in the year 2019.       
  • The factors such as development of new and improved vaccinations for several diseases is a major factor projected to impel growth of Vaccines Market.
  • Increase in the supply of vaccines and initiatives taken by government foundations and international organizations which are focused on providing cost-effective and regular immunization are the key factors owing to the growth in the segment during forecast period 2020-2025.

Diseases Type- Segment Analysis
The Bacterial Diseases segment dominated the Vaccines Market. Bacterial Diseases segment held the largest share in the market as these are the first stage of immunization for the new-born babies, simultaneously booster dosages for pediatrics. Viral Disease segment is poised to growth at a rapid pace during the forecast period 2020-2025. This paradigm shift can be attributed to the global pandemic of COVID-19, set to contribute to the increase in overall viral segmental sales in the forecast period of 2020-2025 as most of the leading companies are focused on the research and development of the vaccines for the pandemic.   
Route of Administration Type- Segment Analysis
Based on Route of Administration type, subcutaneous segment held the major share of the market in terms of revenue. The reason behind the dominance is the rising incidence of various bacterial and viral diseases. Subcutaneous vaccines are believed to be more effective as it enters the blood stream directly triggering the immune system of the body. 

By Geography - Segment Analysis
North America dominated the Vaccines Market with a share of 48% in 2019. The application of vaccines has grown rapidly over the last few years. U.S. remains the largest consumer of Vaccines in North America region, owing to the burgeoning cases of infectious diseases and increasing investments by governmental and non-governmental organizations for vaccine development. However, Europe region is estimated to grow at a fast CAGR during the forecast period 2020-2025 owing to the efficient healthcare industry maintained the country. 
Additionally, it is estimated that the global vaccine market is set to grow exponentially during the forecast period owing to the COVID-19 outbreak.

Drivers – Vaccines Market

  • Rising Prevalence of COVID-19 Cases
With the rise in the COVID-19 outbreak in the various countries, vaccine developments have been taking place which can be estimated to drive of the Vaccines Market. Emergency Use Authorization (EUA) allows FDA to grand permission to use unapproved medical products to diagnose, treat or prevent serious, life threatening condition. This authorization would result in faster approval period for vaccines acting as a key driver of the market during the forecast period. 
Challenges – Vaccines Market

  • High Cost from development to compliance of Vaccines 
The major challenge for the market is the high costs associated to the developments and compliance of these vaccines in a vast and heterogeneous market. The stringent rules and regulations regarding the efficacy of the vaccines also dissuades companies to enter the market. 

Vaccines Industry Outlook
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Vaccines Market. In 2019, Vaccines Market share is fragmented by the top ten players present in the market. Vaccines Market top 10 companies are Glaxo Smith Kline plc., Sanofi, Pfizer Inc., Merck & Co. Inc., Novartis AG, Astra Zeneca, Bavarian Nordic, Serum Institute of India Pvt. Ltd., Bharat Biotech, Sinovac Biotech Ltd.

Acquisitions/Product Launches
  • In April 14, 2020 GSK and Sanofi announced through a letter of intent to enter into a collaboration to develop an adjuvant vaccine for COVID-19, using innovative technology from both companies, to help address the ongoing pandemic.
  • In April 16, 2020 Sanofi and Luminostics have signed an agreement to evaluate a collaboration on a unique self-testing solution for COVID-19, using Luminostics’ innovative technology, and further adding to Sanofi’s ongoing efforts to fight the COVID-19 pandemic on multiple fronts.
  • In December 9, 2019 Bavarian Nordic announced, that its partner Janssen Pharmaceutical Companies of Johnson & Johnson will provide up to 200,000 regimens of its investigational Ebola vaccine to the Republic of Rwanda to support a new immunization program led by the Rwanda government which will help protect the citizens of Rwanda from the current Ebola outbreak in the neighboring country, the Democratic Republic of Congo (DRC).

1. Vaccines Market - Market Overview
    1.1 Definitions and Scope
2. Vaccines Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Disease Indication
    2.3 Key trends by Geography
3. Vaccines Market – Comparative Analysis
    3.1 Product Benchmarking
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Vaccines Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Vaccines Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Vaccines Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Vaccines Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Vaccines Market – By Vaccines Valence (Market Size –$Million/$Billion)
    8.1 Monovalent
    8.2 Multivalent
9. Vaccines Market – By Vaccines Type (Market Size –$Million/$Billion)
    9.1 Live Attenuated Vaccines
    9.2 Inactivated and Subunit Vaccines
    9.3 Toxoid Vaccines 
    9.4 Conjugate Vaccines
    9.5 Recombinant Vaccines
    9.6 Travel Vaccines
    9.7 Others
10. Vaccines Market – By Disease Indication (Market Size –$Million/$Billion)
    10.1 Bacterial Diseases
        10.1.1 Pneumococcal Disease
        10.1.2 Diphtheria
        10.1.3 Tetanus
        10.1.4 Pertussis
        10.1.5 Meningococcal Disease
        10.1.6 Tuberculosis
        10.1.7 Others
    10.2 Viral Diseases
        10.2.1 Human Papilloma Virus
        10.2.2 Polio
        10.2.3 Encephalitis
        10.2.4 Yellow Fever
        10.2.5 Rotavirus
        10.2.6 Hepatitis
        10.2.7 Measles
        10.2.8 Mumps
        10.2.9 Rubella
        10.2.10 Varicella
        10.2.11 Coronavirus
        10.2.12 Others 
11. Vaccines Market – By Route of Administration (Market Size –$Million/$Billion)
    11.1 Intramuscular (IM)
    11.2 Subcutaneous (SC)
    11.3 Oral
    11.4 Other 
12. Vaccines Market – By End-User (Market Size –$Million/$Billion)
    12.1 Adults
    12.2 Pediatrics
13. Vaccines Market – By Distribution Channel (Market Size –$Million/$Billion)
    13.1 Hospital & Retail Pharmacies
    13.2 Government Suppliers
    13.3 Others
14. Vaccines Market - By Geography 
    14.1 North America
        14.1.1 U.S.
        14.1.2 Canada
        14.1.3 Mexico
    14.2 Europe
        14.2.1 UK
        14.2.2 Germany
        14.2.3 France
        14.2.4 Italy
        14.2.5 Spain
        14.2.6 Netherlands
        14.2.7 Rest of Europe
    14.3 Asia Pacific
        14.3.1 China
        14.3.2 India
        14.3.3 Japan
        14.3.4 Australia & New Zealand
        14.3.5 South Korea
        14.3.6 Rest of APAC
    14.4 Rest of World
        14.4.1 Middle East
        14.4.2 Africa
        14.4.3 South America
15. Vaccines Market - Entropy
16. Vaccines Market – Industry/Segment Competition Landscape  (Premium) 
    16.1 Market Share Analysis
        16.1.1 Global Market Share – Key Companies
        16.1.2 Regional Market Share – Key Companies
        16.1.3 Best Practices for Companies
17. Vaccines Market – Key Company List by Country Premium (Premium)
18. Vaccines Market Company Analysis (Company Revenue, Products, M&A, Developments)
    18.1 Company 1
    18.2 Company 2
    18.3 Company 3
    18.4 Company 4
    18.5 Company 5
    18.6 Company 6
    18.7 Company 7
    18.8 Company 8
    18.9 Company 9
    18.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

List of Tables

Table 1 Global Vaccines Market, Key Vaccines by Country, 2018
Table 2 Global Vaccines Market Revenue ($m), By Company, 2018
Table 3 Global Vaccines Market Competitor Benchmarking
Table 4 Major Government Regulations 
Table 5 The Ease of Doing Business Index: Top Countries
Table 6 Global Vaccines Market: Children aged 19-35 months receiving vaccinations in U.S. (%), 2018
Table 7 Vaccines Market, Key Company List by Key Country, 2018
Table 8 Assumptions & Research Methodology for Global Vaccines Market
Table 9 Secondary Sources: Global Vaccines Market (Partial List)
Table 10 Primary Sources: Global Vaccines Market (Partial List)

List of Figures

Figure1 Global Vaccines Market, PESTLE Analysis
Figure2 Global Vaccines Value share - By Geography 2018, 2023 (%)
Figure3 Global Vaccines Market CAGR (%) – By Geography 
Figure4 Global Vaccines Value share - By Technology 2018, 2023 (%)
Figure5 Global Vaccines Market CAGR (%) – By Technology
Figure6 Pfizer Inc.
Figure7 Merck & Co., Inc.
Figure8 GlaxoSmithKline plc
Figure9 Sanofi
Figure10 CSL Limited
Figure11 EPS, By Company, 2015-2018 ($/Share)
Figure12 Global Human Vaccines Market, Number of Patents, 2014 – 2019*
Figure13 Global Human Vaccines Market, Number of Patents, By Country, 2014 – 2018*
Figure14 Global Vaccines Market, Market Share, By Company, 2018 (%)
Figure15 Global Vaccines Market Startup Investment, 2014 – March* 2019, ($Million)
Figure16 Global Vaccines Market Investment Share, By Company (Startup) (%)
Figure17 Global Vaccines Market, Value Chain Analysis
Figure18 Figure: Global Vaccines Market Life Cycle, 2018–2023
Figure19 Global Vaccines Market Segmentation – By Technology
Figure20 Global Vaccines Market Growth Rate- By Technology, 2018–2023 (%)
Figure21 Global Vaccines Market Segmentation – By Disease Indication
Figure22 Global Vaccines Market Growth Rate- By Disease Indication, 2018–2023 (%)
Figure23 Global Vaccines Market Segmentation – By End User
Figure24 Global Vaccines Market Growth Rate- By End user, 2018–2023 (%)
Figure25 Global Vaccines Market Entropy Share, By Strategies, 2016--2019* (%)
Figure26 Global Vaccines Market Entropy, By Total Number of Developments, 2016-2019*